npj Breast Cancer

Content-Length: 210550 | pFad | http://www.nature.com/npjbcancer/

ma=86400 npj Breast Cancer

npj Breast Cancer banner

New collections open to submissions

Featured

Emerging systemic therapy options beyond CDK4/6 inhibitors for hormone receptor-positive HER2-negative advanced breast cancer

Jun Ma
Jack Junjie Chan
Yoon-Sim Yap
Review ArticleOpen Access08 Sept 2023
Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer

Mohammadhadi Khorrami
Vidya Sakar Viswanathan
Anant Madabhushi
ArticleOpen Access11 Aug 2023

Announcements

npj Breast Cancer Journal Metrics

npj Breast Cancer has a 2-year impact factor of 5.9 (2022), article downloads of 742,276 (2022) and 7 days from submission to first editorial decision (2022).
Call for papers: AI in precision oncology

Submit to our new collection focused on AI in precision oncology, deadline: 19 October 2023.
Call for papers: blood biomarkers in breast cancer

Submit to our new collection focused on blood biomarkers in breast cancer, deadline: 31 January 2024.
Follow us on Twitter

Keep up to date with the journal and new publications by following us on Twitter. Share your work by tagging @Nature_NPJ and using our hashtag #npjBCancer.

Browse articles

The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer

Zheqi Li
Fangyuan Chen
Adrian V. Lee
ArticleOpen Access19 Dec 2024
Breast organoid suspension cultures maintain long-term estrogen receptor expression and responsiveness

Kung-Chi Chang
Francesca Silvestri
Joan S. Brugge
ArticleOpen Access19 Dec 2024
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer

Linda Cucciniello
Eva Blondeaux
Fabio Puglisi
ArticleOpen Access18 Dec 2024
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer

Fatima Cardoso
Kim M. Hirshfield
Aditya Bardia
Review ArticleOpen Access06 Dec 2024
Circulating tumor cells in breast cancer: clinical validity and utility

Thibault Thomas-Bonafos
Jean Yves Pierga
Nicolas Kiavue
Review ArticleOpen Access29 Nov 2024
Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative

Su-Jin Shin
Inho Park
Yoon Jin Cha
ArticleOpen Access26 Nov 2024
Palbociclib and letrozole for hormone receptor-positive HER2-negative breast cancer with residual disease after neoadjuvant chemotherapy

Sonia Pernas
Esther Sanfeliu
Eva Ciruelos
ArticleOpen Access26 Nov 2024
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases

Vaseem M. Khatri
Mariella A. Mestres-Villanueva
Kamran A. Ahmed
ArticleOpen Access21 Nov 2024
Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer

Lauren D. Otto-Dobos
Lindsay D. Strehle
Leah M. Pyter
ArticleOpen Access15 Nov 2024

Trending - Altmetric

Science jobs

Postdoctoral fellowship in cancer biomarkers research

Postdoctoral fellowship in cancer biomarkers, center for primary health care research, Department of Clinical Sciences Malmö, Sweden.

Malmö (Stad), Skåne (SE)

Lund University
Tenure-Track Junior PI in Artificial Intelligence for precision oncology

Milan City (IT)

IFOM ETS - The AIRC Institute of Molecular Oncology
Director of the Institute of Cancer Research and Robert and Janet Perro Endowed Chair

Northwell Health has formed a strategic partnership with the NCI-designated Cancer Center at Cold Spring Harbor Laboratory (CSHL). The institutions...

Manhasset, New York

Northwell
Head of the Translational Cancer Research Laboratory

Northwell Health has formed a strategic partnership with the NCI-designated Cancer Center at Cold Spring Harbor Laboratory (CSHL). The institutions...

Manhasset, New York

Northwell
Postdoctoral fellow

Postdoctoral position in Immuno oncology research in NCI designated Sylvester Comprehensive Cancer Center, University of Miami

Miami, Florida (US)

Sylvester comprehensive cancer center, Miller School of Medicine, University of Miami

Advertisement

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

Search

Advanced search

Quick links